Clinical trial
Study Of An Investigational Regimen Including FDA Approved HIV Drugs In…
NCT00071760 · ViiV Healthcare, Industry · Completed
Key facts
| NCT number | NCT00071760 |
|---|---|
| Title | Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects |
| Official title | A 48 Week, Phase II, Open-label, 2-cohort, Multicenter Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Antiviral Activity of GW433908 and GW433908/RTV When Administered to HIV-1 Infected Protease Inhibitor (PI) Naive and PI-experienced Pediatric Subjects Aged 4 Weeks to <2 Years. |
| Lead sponsor | ViiV Healthcare, Industry |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Infection, Human Immunodeficiency Virus, HIV Infections |
| Intervention type | Drug |
| Interventions | GW433908, ritonavir |
| Enrollment | 59 |
| Start date | Oct 23, 2003 |
| Primary completion | Jul 5, 2011 |
| Completion | Mar 29, 2022 |
| First posted | Oct 31, 2003 |
| Last update posted | Oct 10, 2023 |
| Countries | Argentina, Mexico, Portugal, Puerto Rico, Russia, South Africa, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: